Amgen Wins Arbitration and Awarded $150 Million Against Johnson & Johnson Read more about Amgen Wins Arbitration and Awarded $150 Million Against Johnson & Johnson
Amgen And Wyeth Pharmaceuticals Announce Initiation Of Landmark Study In Rheumatoid Arthritis Read more about Amgen And Wyeth Pharmaceuticals Announce Initiation Of Landmark Study In Rheumatoid Arthritis
Amgen Submits Data To FDA Supporting Use Of Enbrel To Improve Physical Function In Rheumatoid Arthritis Patients Read more about Amgen Submits Data To FDA Supporting Use Of Enbrel To Improve Physical Function In Rheumatoid Arthritis Patients
Rob Lowe Introduces One-To-One Support Network For New Cancer Patients Read more about Rob Lowe Introduces One-To-One Support Network For New Cancer Patients
Amgen Announces Filing With FDA For Licensure Of Enbrel Production Facility In Rhode Island Read more about Amgen Announces Filing With FDA For Licensure Of Enbrel Production Facility In Rhode Island
Second Quarter 2002 Earnings Per Share Increase 27 Percent To 38 Cents Read more about Second Quarter 2002 Earnings Per Share Increase 27 Percent To 38 Cents
FDA Approves Amgen's Aranesp For Anemia Associated With Chemotherapy Read more about FDA Approves Amgen's Aranesp For Anemia Associated With Chemotherapy
Amgen Receives CPMP Recommendation For European Union Marketing Approval Of Neulasta For The Reduction Of Chemotherapy - Induced Neutropenia Read more about Amgen Receives CPMP Recommendation For European Union Marketing Approval Of Neulasta For The Reduction Of Chemotherapy - Induced Neutropenia
